Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Transcranial Magnetic Stimulation | 166 | 2024 | 1433 | 18.200 |
Why?
|
Motor Cortex | 78 | 2024 | 986 | 14.720 |
Why?
|
Electric Stimulation Therapy | 82 | 2019 | 605 | 13.840 |
Why?
|
Phantom Limb | 15 | 2024 | 91 | 8.140 |
Why?
|
Fibromyalgia | 26 | 2023 | 388 | 7.070 |
Why?
|
Prefrontal Cortex | 77 | 2023 | 2147 | 6.020 |
Why?
|
Electric Stimulation | 49 | 2023 | 1767 | 4.750 |
Why?
|
Neuralgia | 23 | 2021 | 570 | 4.620 |
Why?
|
Spinal Cord Injuries | 21 | 2022 | 931 | 4.520 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 14 | 2024 | 162 | 4.470 |
Why?
|
Evoked Potentials, Motor | 33 | 2022 | 454 | 4.420 |
Why?
|
Pain Threshold | 30 | 2023 | 584 | 4.130 |
Why?
|
Neuronal Plasticity | 37 | 2021 | 1423 | 3.840 |
Why?
|
Depressive Disorder, Major | 46 | 2024 | 4639 | 3.470 |
Why?
|
Vagus Nerve Stimulation | 7 | 2024 | 200 | 3.240 |
Why?
|
Osteoarthritis, Knee | 11 | 2023 | 1222 | 3.020 |
Why?
|
Double-Blind Method | 98 | 2024 | 12025 | 2.900 |
Why?
|
Electroencephalography | 40 | 2024 | 6151 | 2.900 |
Why?
|
Pain Measurement | 56 | 2023 | 3420 | 2.860 |
Why?
|
Exercise Therapy | 16 | 2023 | 904 | 2.480 |
Why?
|
Sertraline | 10 | 2016 | 206 | 2.460 |
Why?
|
Brain | 73 | 2024 | 26388 | 2.460 |
Why?
|
Pain Perception | 8 | 2022 | 191 | 2.420 |
Why?
|
Pain | 40 | 2024 | 4988 | 2.400 |
Why?
|
Brain-Derived Neurotrophic Factor | 26 | 2023 | 604 | 2.310 |
Why?
|
Cerebral Cortex | 36 | 2018 | 5709 | 2.310 |
Why?
|
Stroke | 46 | 2023 | 9981 | 2.120 |
Why?
|
Functional Laterality | 33 | 2020 | 2290 | 2.040 |
Why?
|
Pyramidal Tracts | 11 | 2019 | 256 | 2.000 |
Why?
|
Beta Rhythm | 4 | 2022 | 58 | 1.840 |
Why?
|
Deep Brain Stimulation | 16 | 2014 | 748 | 1.700 |
Why?
|
Humans | 474 | 2024 | 744366 | 1.640 |
Why?
|
Analgesia | 9 | 2023 | 461 | 1.600 |
Why?
|
Models, Neurological | 15 | 2021 | 1775 | 1.500 |
Why?
|
Hyperalgesia | 11 | 2020 | 502 | 1.420 |
Why?
|
Dominance, Cerebral | 10 | 2010 | 635 | 1.410 |
Why?
|
Adult | 209 | 2024 | 214052 | 1.380 |
Why?
|
Theta Rhythm | 3 | 2022 | 207 | 1.360 |
Why?
|
Male | 275 | 2024 | 350115 | 1.360 |
Why?
|
Treatment Outcome | 119 | 2024 | 63107 | 1.310 |
Why?
|
Neural Inhibition | 8 | 2021 | 602 | 1.300 |
Why?
|
Recovery of Function | 22 | 2023 | 2926 | 1.290 |
Why?
|
Parkinson Disease | 16 | 2023 | 2775 | 1.280 |
Why?
|
Female | 270 | 2024 | 380193 | 1.270 |
Why?
|
Cognition | 29 | 2023 | 6770 | 1.260 |
Why?
|
Attention | 15 | 2021 | 2397 | 1.250 |
Why?
|
Fluoxetine | 6 | 2019 | 749 | 1.250 |
Why?
|
Motor Activity | 14 | 2020 | 2715 | 1.240 |
Why?
|
Cerebral Palsy | 9 | 2016 | 459 | 1.240 |
Why?
|
Autonomic Nervous System | 4 | 2024 | 672 | 1.230 |
Why?
|
Burns | 6 | 2020 | 1815 | 1.210 |
Why?
|
Middle Aged | 173 | 2024 | 213390 | 1.200 |
Why?
|
Combined Modality Therapy | 31 | 2021 | 8642 | 1.160 |
Why?
|
Electrodes | 14 | 2020 | 619 | 1.160 |
Why?
|
Electroconvulsive Therapy | 7 | 2010 | 477 | 1.140 |
Why?
|
Cross-Over Studies | 25 | 2021 | 2029 | 1.120 |
Why?
|
Motor Skills | 12 | 2019 | 522 | 1.110 |
Why?
|
Clinical Trials as Topic | 12 | 2019 | 7914 | 1.110 |
Why?
|
Patient Dropouts | 2 | 2019 | 420 | 1.100 |
Why?
|
Brain Waves | 5 | 2021 | 401 | 1.090 |
Why?
|
Memory, Short-Term | 12 | 2018 | 977 | 1.050 |
Why?
|
Somatosensory Cortex | 5 | 2020 | 528 | 1.050 |
Why?
|
Psychomotor Performance | 17 | 2017 | 1901 | 1.030 |
Why?
|
Antidepressive Agents | 13 | 2013 | 2838 | 1.020 |
Why?
|
Peripheral Nerves | 3 | 2020 | 466 | 1.000 |
Why?
|
Hand | 13 | 2021 | 884 | 1.000 |
Why?
|
Sleep Initiation and Maintenance Disorders | 3 | 2023 | 1004 | 0.990 |
Why?
|
Epilepsy | 12 | 2016 | 3310 | 0.990 |
Why?
|
Amylases | 2 | 2015 | 173 | 0.990 |
Why?
|
Young Adult | 80 | 2022 | 56429 | 0.940 |
Why?
|
Affect | 14 | 2015 | 1475 | 0.930 |
Why?
|
Neuropsychological Tests | 32 | 2020 | 6994 | 0.910 |
Why?
|
Randomized Controlled Trials as Topic | 19 | 2023 | 9955 | 0.890 |
Why?
|
Alpha Rhythm | 3 | 2021 | 120 | 0.880 |
Why?
|
Lipase | 2 | 2015 | 314 | 0.850 |
Why?
|
Depressive Disorder | 9 | 2023 | 3747 | 0.850 |
Why?
|
Biomedical Research | 7 | 2014 | 3309 | 0.840 |
Why?
|
Brain Diseases | 4 | 2021 | 1563 | 0.840 |
Why?
|
Postural Balance | 5 | 2023 | 620 | 0.830 |
Why?
|
Depression | 22 | 2023 | 7759 | 0.820 |
Why?
|
Movement | 7 | 2014 | 1471 | 0.810 |
Why?
|
Analysis of Variance | 30 | 2017 | 6366 | 0.780 |
Why?
|
Lower Extremity | 5 | 2024 | 1158 | 0.780 |
Why?
|
Paresis | 5 | 2019 | 179 | 0.770 |
Why?
|
Evoked Potentials, Auditory | 2 | 2016 | 525 | 0.770 |
Why?
|
Rats, Wistar | 22 | 2023 | 1892 | 0.770 |
Why?
|
Motor Neurons | 3 | 2015 | 844 | 0.770 |
Why?
|
Brazil | 15 | 2024 | 1270 | 0.760 |
Why?
|
Imagination | 2 | 2015 | 221 | 0.760 |
Why?
|
Reaction Time | 17 | 2017 | 2098 | 0.750 |
Why?
|
Levodopa | 5 | 2016 | 219 | 0.750 |
Why?
|
Aged | 96 | 2023 | 163288 | 0.740 |
Why?
|
Photic Stimulation | 18 | 2015 | 2026 | 0.740 |
Why?
|
Frontal Lobe | 6 | 2014 | 1406 | 0.740 |
Why?
|
Nervous System Diseases | 4 | 2019 | 1622 | 0.730 |
Why?
|
Pruritus | 3 | 2019 | 361 | 0.720 |
Why?
|
Pain, Intractable | 1 | 2021 | 130 | 0.720 |
Why?
|
Amputees | 4 | 2021 | 75 | 0.700 |
Why?
|
Pelvic Pain | 2 | 2014 | 274 | 0.700 |
Why?
|
Aphasia | 5 | 2017 | 184 | 0.690 |
Why?
|
Cross-Sectional Studies | 28 | 2023 | 25039 | 0.680 |
Why?
|
Gait | 4 | 2020 | 793 | 0.680 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2022 | 271 | 0.660 |
Why?
|
Brain Mapping | 20 | 2021 | 6670 | 0.660 |
Why?
|
Skull | 5 | 2012 | 814 | 0.660 |
Why?
|
Learning | 11 | 2018 | 1711 | 0.640 |
Why?
|
Placebo Effect | 7 | 2020 | 502 | 0.640 |
Why?
|
Myofascial Pain Syndromes | 6 | 2016 | 35 | 0.640 |
Why?
|
Antidepressive Agents, Second-Generation | 4 | 2017 | 503 | 0.640 |
Why?
|
Persistent Vegetative State | 4 | 2023 | 260 | 0.640 |
Why?
|
Rehabilitation | 2 | 2010 | 134 | 0.630 |
Why?
|
Pilot Projects | 17 | 2021 | 8319 | 0.630 |
Why?
|
Thiopental | 2 | 2008 | 59 | 0.620 |
Why?
|
Low Back Pain | 3 | 2022 | 956 | 0.610 |
Why?
|
Sensation | 4 | 2021 | 336 | 0.610 |
Why?
|
Muscle, Skeletal | 5 | 2023 | 4925 | 0.610 |
Why?
|
Arthralgia | 1 | 2022 | 456 | 0.610 |
Why?
|
Pancreatitis | 2 | 2015 | 1092 | 0.600 |
Why?
|
Upper Extremity | 7 | 2023 | 648 | 0.600 |
Why?
|
Problem Solving | 3 | 2016 | 440 | 0.590 |
Why?
|
Quality of Life | 17 | 2023 | 12802 | 0.590 |
Why?
|
Heart Rate | 10 | 2024 | 4092 | 0.580 |
Why?
|
Diabetic Neuropathies | 1 | 2020 | 400 | 0.580 |
Why?
|
Magnetics | 7 | 2005 | 606 | 0.580 |
Why?
|
Publications | 1 | 2019 | 195 | 0.570 |
Why?
|
Cortical Synchronization | 2 | 2022 | 79 | 0.560 |
Why?
|
Decision Making | 8 | 2014 | 3888 | 0.560 |
Why?
|
Mental Disorders | 10 | 2021 | 6598 | 0.560 |
Why?
|
Robotics | 8 | 2021 | 899 | 0.560 |
Why?
|
Psychiatric Status Rating Scales | 21 | 2017 | 6036 | 0.550 |
Why?
|
Galvanic Skin Response | 2 | 2016 | 349 | 0.550 |
Why?
|
Cortical Spreading Depression | 4 | 2012 | 276 | 0.550 |
Why?
|
Seizures | 6 | 2020 | 2859 | 0.550 |
Why?
|
Corpus Callosum | 3 | 2018 | 737 | 0.540 |
Why?
|
Pancreatitis, Chronic | 2 | 2010 | 285 | 0.540 |
Why?
|
Research Design | 10 | 2017 | 5984 | 0.530 |
Why?
|
Language Disorders | 2 | 2013 | 141 | 0.530 |
Why?
|
Cues | 7 | 2014 | 875 | 0.530 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2014 | 3759 | 0.530 |
Why?
|
Risk-Taking | 4 | 2014 | 986 | 0.520 |
Why?
|
Motor Skills Disorders | 2 | 2013 | 90 | 0.520 |
Why?
|
Publishing | 2 | 2013 | 833 | 0.520 |
Why?
|
Adolescent | 57 | 2022 | 85779 | 0.520 |
Why?
|
Chronic Disease | 24 | 2019 | 9145 | 0.520 |
Why?
|
Etomidate | 2 | 2008 | 190 | 0.510 |
Why?
|
Cognition Disorders | 9 | 2013 | 4043 | 0.510 |
Why?
|
Placebos | 6 | 2019 | 1676 | 0.500 |
Why?
|
Ketamine | 1 | 2021 | 501 | 0.500 |
Why?
|
Electroencephalography Phase Synchronization | 1 | 2014 | 10 | 0.500 |
Why?
|
Computer Simulation | 11 | 2017 | 6194 | 0.490 |
Why?
|
Dopamine Agents | 2 | 2016 | 189 | 0.490 |
Why?
|
Parietal Lobe | 5 | 2013 | 838 | 0.480 |
Why?
|
Vagus Nerve | 4 | 2024 | 439 | 0.480 |
Why?
|
Auditory Perception | 2 | 2016 | 569 | 0.480 |
Why?
|
Cerebellum | 4 | 2023 | 1488 | 0.480 |
Why?
|
Single-Blind Method | 9 | 2020 | 1590 | 0.470 |
Why?
|
Temporal Lobe | 6 | 2014 | 1670 | 0.470 |
Why?
|
Ataxia | 1 | 2016 | 304 | 0.470 |
Why?
|
Citalopram | 3 | 2017 | 403 | 0.460 |
Why?
|
Bipolar Disorder | 5 | 2017 | 5027 | 0.460 |
Why?
|
Time Factors | 38 | 2021 | 40075 | 0.460 |
Why?
|
Hyperphagia | 2 | 2015 | 136 | 0.450 |
Why?
|
Prader-Willi Syndrome | 2 | 2015 | 79 | 0.450 |
Why?
|
Activities of Daily Living | 4 | 2022 | 2419 | 0.450 |
Why?
|
Electromyography | 8 | 2022 | 1379 | 0.450 |
Why?
|
Restraint, Physical | 4 | 2015 | 193 | 0.450 |
Why?
|
Alcoholism | 4 | 2014 | 1906 | 0.440 |
Why?
|
Tinnitus | 4 | 2011 | 195 | 0.440 |
Why?
|
Electromagnetic Fields | 5 | 2010 | 298 | 0.440 |
Why?
|
Sensation Disorders | 1 | 2014 | 156 | 0.440 |
Why?
|
Apathy | 1 | 2013 | 96 | 0.430 |
Why?
|
Trigeminal Nerve | 1 | 2014 | 249 | 0.430 |
Why?
|
Catastrophization | 4 | 2021 | 316 | 0.430 |
Why?
|
Pain, Postoperative | 3 | 2023 | 1643 | 0.430 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2016 | 403 | 0.430 |
Why?
|
Mobility Limitation | 2 | 2015 | 409 | 0.420 |
Why?
|
Latin America | 3 | 2023 | 380 | 0.420 |
Why?
|
Movement Disorders | 2 | 2015 | 446 | 0.410 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2013 | 243 | 0.400 |
Why?
|
Rats | 24 | 2023 | 24252 | 0.390 |
Why?
|
Sensory Thresholds | 3 | 2017 | 391 | 0.390 |
Why?
|
Propofol | 2 | 2008 | 629 | 0.390 |
Why?
|
Severity of Illness Index | 17 | 2022 | 15535 | 0.390 |
Why?
|
Amantadine | 1 | 2011 | 55 | 0.390 |
Why?
|
Genetic Diseases, Inborn | 1 | 2016 | 587 | 0.390 |
Why?
|
Quadriplegia | 2 | 2015 | 223 | 0.380 |
Why?
|
Spectroscopy, Near-Infrared | 3 | 2024 | 721 | 0.380 |
Why?
|
Visual Perception | 6 | 2015 | 1420 | 0.370 |
Why?
|
Anesthesia, Intravenous | 2 | 2008 | 130 | 0.370 |
Why?
|
Fatigue | 4 | 2023 | 1531 | 0.370 |
Why?
|
Memory | 8 | 2011 | 2174 | 0.370 |
Why?
|
Abdominal Pain | 2 | 2007 | 1064 | 0.360 |
Why?
|
Magnetic Resonance Imaging | 28 | 2023 | 35425 | 0.360 |
Why?
|
Patient Selection | 4 | 2019 | 4216 | 0.360 |
Why?
|
Methylphenidate | 1 | 2014 | 473 | 0.350 |
Why?
|
Tension-Type Headache | 3 | 2023 | 77 | 0.350 |
Why?
|
Facial Pain | 2 | 2014 | 127 | 0.350 |
Why?
|
Antiparkinson Agents | 3 | 2006 | 184 | 0.340 |
Why?
|
Judgment | 2 | 2008 | 281 | 0.340 |
Why?
|
MEDLINE | 4 | 2011 | 125 | 0.340 |
Why?
|
Electric Conductivity | 1 | 2009 | 411 | 0.340 |
Why?
|
Physical Stimulation | 2 | 2010 | 525 | 0.330 |
Why?
|
Forecasting | 4 | 2020 | 2951 | 0.330 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7282 | 0.330 |
Why?
|
Meta-Analysis as Topic | 3 | 2021 | 1342 | 0.330 |
Why?
|
Memory Disorders | 4 | 2011 | 1186 | 0.320 |
Why?
|
Arm | 4 | 2019 | 589 | 0.320 |
Why?
|
Nerve Net | 5 | 2012 | 2175 | 0.320 |
Why?
|
Vulvar Diseases | 1 | 2008 | 61 | 0.320 |
Why?
|
Hippocampus | 4 | 2021 | 3675 | 0.320 |
Why?
|
Migraine Disorders | 3 | 2023 | 1620 | 0.320 |
Why?
|
Animals | 47 | 2024 | 168768 | 0.320 |
Why?
|
Vestibular Diseases | 1 | 2011 | 217 | 0.320 |
Why?
|
Trigeminal Neuralgia | 1 | 2009 | 113 | 0.320 |
Why?
|
Psychopharmacology | 1 | 2010 | 143 | 0.320 |
Why?
|
Thalamus | 2 | 2011 | 1023 | 0.310 |
Why?
|
Pattern Recognition, Visual | 7 | 2012 | 824 | 0.310 |
Why?
|
Disability Evaluation | 6 | 2017 | 1828 | 0.310 |
Why?
|
Evidence-Based Medicine | 5 | 2021 | 3611 | 0.310 |
Why?
|
Neurotransmitter Agents | 2 | 2010 | 647 | 0.300 |
Why?
|
Sample Size | 1 | 2011 | 845 | 0.300 |
Why?
|
Alzheimer Disease | 4 | 2013 | 8038 | 0.300 |
Why?
|
Models, Biological | 5 | 2020 | 9584 | 0.290 |
Why?
|
Marijuana Smoking | 1 | 2010 | 253 | 0.290 |
Why?
|
Encephalitis | 1 | 2010 | 425 | 0.290 |
Why?
|
Stress, Psychological | 3 | 2017 | 4245 | 0.290 |
Why?
|
Bone Plates | 1 | 2010 | 468 | 0.290 |
Why?
|
Video Games | 2 | 2023 | 184 | 0.290 |
Why?
|
Brain Injuries | 5 | 2014 | 2029 | 0.290 |
Why?
|
Follow-Up Studies | 19 | 2019 | 39052 | 0.290 |
Why?
|
Physical Conditioning, Animal | 2 | 2021 | 354 | 0.290 |
Why?
|
Rest | 2 | 2022 | 901 | 0.290 |
Why?
|
Myoclonic Epilepsy, Juvenile | 1 | 2006 | 11 | 0.280 |
Why?
|
Spinal Cord | 7 | 2021 | 1810 | 0.280 |
Why?
|
Emotions | 7 | 2015 | 2659 | 0.280 |
Why?
|
Anxiety | 12 | 2022 | 4293 | 0.280 |
Why?
|
Analgesics | 6 | 2022 | 1040 | 0.280 |
Why?
|
Gambling | 1 | 2010 | 250 | 0.280 |
Why?
|
Interleukin-10 | 7 | 2023 | 1200 | 0.280 |
Why?
|
Neural Pathways | 9 | 2021 | 2974 | 0.270 |
Why?
|
Education, Distance | 1 | 2010 | 251 | 0.270 |
Why?
|
Melatonin | 3 | 2020 | 721 | 0.270 |
Why?
|
Exercise | 3 | 2023 | 5615 | 0.270 |
Why?
|
Viscera | 1 | 2006 | 139 | 0.270 |
Why?
|
Electricity | 1 | 2006 | 182 | 0.260 |
Why?
|
Anticonvulsants | 3 | 2020 | 1916 | 0.260 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2009 | 333 | 0.260 |
Why?
|
Central Nervous System Stimulants | 1 | 2014 | 1148 | 0.260 |
Why?
|
Paralysis | 1 | 2006 | 247 | 0.260 |
Why?
|
Telemedicine | 1 | 2022 | 2872 | 0.260 |
Why?
|
Research | 2 | 2011 | 1999 | 0.260 |
Why?
|
Central Nervous System | 3 | 2015 | 1357 | 0.260 |
Why?
|
Crack Cocaine | 2 | 2015 | 32 | 0.250 |
Why?
|
Internationality | 2 | 2011 | 1002 | 0.250 |
Why?
|
Finite Element Analysis | 5 | 2021 | 431 | 0.250 |
Why?
|
Research Personnel | 1 | 2010 | 573 | 0.250 |
Why?
|
Diffusion of Innovation | 1 | 2010 | 725 | 0.250 |
Why?
|
Facial Expression | 1 | 2008 | 508 | 0.250 |
Why?
|
Safety | 4 | 2017 | 1186 | 0.250 |
Why?
|
Databases, Bibliographic | 2 | 2018 | 128 | 0.240 |
Why?
|
Behavior | 4 | 2015 | 561 | 0.240 |
Why?
|
Spinal Osteophytosis | 1 | 2004 | 29 | 0.240 |
Why?
|
Food Preferences | 1 | 2007 | 399 | 0.240 |
Why?
|
Random Allocation | 5 | 2016 | 2428 | 0.240 |
Why?
|
Phrenic Nerve | 1 | 2004 | 79 | 0.230 |
Why?
|
Hemiplegia | 2 | 2016 | 135 | 0.230 |
Why?
|
Opioid-Related Disorders | 1 | 2018 | 2064 | 0.230 |
Why?
|
Verbal Behavior | 3 | 2012 | 339 | 0.230 |
Why?
|
Internet | 3 | 2010 | 3056 | 0.230 |
Why?
|
Muscle Strength | 3 | 2020 | 592 | 0.230 |
Why?
|
Survivors | 4 | 2022 | 2291 | 0.230 |
Why?
|
Wallerian Degeneration | 1 | 2003 | 69 | 0.230 |
Why?
|
Anesthetics, Intravenous | 1 | 2007 | 417 | 0.230 |
Why?
|
Feasibility Studies | 6 | 2019 | 5077 | 0.230 |
Why?
|
Therapy, Computer-Assisted | 2 | 2019 | 271 | 0.230 |
Why?
|
Electrophysiological Phenomena | 2 | 2017 | 315 | 0.230 |
Why?
|
Occipital Lobe | 5 | 2008 | 379 | 0.230 |
Why?
|
Organ Transplantation | 1 | 2014 | 1140 | 0.230 |
Why?
|
Subclavian Steal Syndrome | 1 | 2003 | 23 | 0.230 |
Why?
|
Valproic Acid | 1 | 2006 | 445 | 0.230 |
Why?
|
Substance-Related Disorders | 2 | 2019 | 4257 | 0.220 |
Why?
|
Peripheral Nervous System | 2 | 2019 | 150 | 0.220 |
Why?
|
Executive Function | 4 | 2021 | 1364 | 0.220 |
Why?
|
Sleep | 6 | 2023 | 4622 | 0.220 |
Why?
|
Prospective Studies | 14 | 2023 | 53290 | 0.220 |
Why?
|
Home Care Services | 2 | 2020 | 606 | 0.220 |
Why?
|
Muscle Contraction | 2 | 2022 | 1235 | 0.220 |
Why?
|
Deglutition Disorders | 1 | 2008 | 606 | 0.220 |
Why?
|
Subclavian Artery | 1 | 2003 | 130 | 0.220 |
Why?
|
Anesthetics | 1 | 2008 | 539 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3135 | 0.210 |
Why?
|
Voice Disorders | 1 | 2006 | 276 | 0.210 |
Why?
|
Fires | 2 | 2014 | 173 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3242 | 0.210 |
Why?
|
Aged, 80 and over | 14 | 2022 | 57776 | 0.210 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2011 | 1444 | 0.210 |
Why?
|
Proprioception | 1 | 2023 | 132 | 0.210 |
Why?
|
Physical Therapy Modalities | 5 | 2023 | 550 | 0.200 |
Why?
|
Spinal Cord Compression | 1 | 2004 | 235 | 0.200 |
Why?
|
Hand Strength | 3 | 2022 | 448 | 0.200 |
Why?
|
Postpartum Period | 1 | 2008 | 1086 | 0.200 |
Why?
|
Memory, Long-Term | 2 | 2021 | 64 | 0.200 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1888 | 0.200 |
Why?
|
Dose-Response Relationship, Radiation | 4 | 2008 | 876 | 0.200 |
Why?
|
Reference Values | 5 | 2016 | 4982 | 0.200 |
Why?
|
Hypnotics and Sedatives | 2 | 2012 | 1162 | 0.190 |
Why?
|
Cocaine-Related Disorders | 2 | 2015 | 460 | 0.190 |
Why?
|
Resistance Training | 1 | 2023 | 164 | 0.190 |
Why?
|
Models, Animal | 3 | 2023 | 2173 | 0.190 |
Why?
|
Language | 5 | 2013 | 1471 | 0.190 |
Why?
|
Neurology | 1 | 2009 | 763 | 0.190 |
Why?
|
Locomotion | 2 | 2021 | 378 | 0.190 |
Why?
|
Aspartic Acid | 3 | 2012 | 576 | 0.190 |
Why?
|
Aphasia, Broca | 2 | 2011 | 50 | 0.190 |
Why?
|
Hot Temperature | 4 | 2015 | 1356 | 0.180 |
Why?
|
Evoked Potentials | 5 | 2021 | 1056 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.180 |
Why?
|
Rabbits | 2 | 2017 | 4894 | 0.180 |
Why?
|
Physician Impairment | 1 | 2020 | 73 | 0.180 |
Why?
|
Antipsychotic Agents | 2 | 2010 | 3057 | 0.170 |
Why?
|
Cardiovascular System | 1 | 2007 | 831 | 0.170 |
Why?
|
Orientation | 1 | 2021 | 327 | 0.170 |
Why?
|
General Surgery | 1 | 2011 | 1636 | 0.170 |
Why?
|
Behavior, Animal | 2 | 2018 | 1881 | 0.170 |
Why?
|
Cardiology | 1 | 2010 | 1668 | 0.170 |
Why?
|
Consciousness Disorders | 2 | 2023 | 418 | 0.170 |
Why?
|
Neurologic Examination | 4 | 2011 | 931 | 0.170 |
Why?
|
Teaching | 3 | 2015 | 1174 | 0.170 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2018 | 3658 | 0.170 |
Why?
|
Period Circadian Proteins | 1 | 2019 | 102 | 0.170 |
Why?
|
Sjogren's Syndrome | 1 | 2020 | 234 | 0.170 |
Why?
|
Asia | 1 | 2020 | 609 | 0.170 |
Why?
|
Angioplasty, Balloon | 1 | 2003 | 653 | 0.160 |
Why?
|
Disease Models, Animal | 10 | 2021 | 18034 | 0.160 |
Why?
|
Child | 17 | 2021 | 77709 | 0.160 |
Why?
|
Minisatellite Repeats | 1 | 2019 | 165 | 0.160 |
Why?
|
Knee Joint | 2 | 2021 | 1680 | 0.160 |
Why?
|
Population Dynamics | 1 | 2020 | 302 | 0.160 |
Why?
|
Africa | 1 | 2020 | 672 | 0.160 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2004 | 685 | 0.160 |
Why?
|
Education, Medical, Graduate | 1 | 2010 | 2291 | 0.160 |
Why?
|
Pressure | 5 | 2014 | 1203 | 0.160 |
Why?
|
Sex Characteristics | 1 | 2008 | 2585 | 0.160 |
Why?
|
Halitosis | 1 | 2017 | 13 | 0.160 |
Why?
|
Diagnostic Equipment | 1 | 2017 | 10 | 0.160 |
Why?
|
Urban Health | 1 | 2020 | 547 | 0.150 |
Why?
|
Neuroblastoma | 2 | 2023 | 1226 | 0.150 |
Why?
|
Electroacupuncture | 2 | 2015 | 60 | 0.150 |
Why?
|
Touch | 2 | 2012 | 306 | 0.150 |
Why?
|
Musculoskeletal Manipulations | 1 | 2017 | 25 | 0.150 |
Why?
|
Research Subjects | 1 | 2019 | 239 | 0.150 |
Why?
|
Tears | 1 | 2018 | 256 | 0.150 |
Why?
|
Hallux Valgus | 1 | 2017 | 65 | 0.150 |
Why?
|
Knee Injuries | 2 | 2012 | 490 | 0.150 |
Why?
|
Diarrhea | 1 | 2004 | 1348 | 0.140 |
Why?
|
Feeding Behavior | 3 | 2016 | 3188 | 0.140 |
Why?
|
Speech Therapy | 2 | 2015 | 57 | 0.140 |
Why?
|
Neurophysiology | 2 | 2008 | 142 | 0.140 |
Why?
|
Smoking | 2 | 2014 | 8987 | 0.140 |
Why?
|
Multivariate Analysis | 4 | 2021 | 12244 | 0.140 |
Why?
|
Hemianopsia | 2 | 2012 | 122 | 0.140 |
Why?
|
Epilepsia Partialis Continua | 1 | 2016 | 18 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2021 | 4424 | 0.140 |
Why?
|
Ethics Committees | 1 | 2016 | 54 | 0.140 |
Why?
|
Quality Control | 2 | 2010 | 841 | 0.140 |
Why?
|
Walking | 2 | 2021 | 1180 | 0.140 |
Why?
|
Behavior, Addictive | 2 | 2013 | 462 | 0.140 |
Why?
|
Authorship | 1 | 2019 | 271 | 0.140 |
Why?
|
Quality-Adjusted Life Years | 1 | 2022 | 1683 | 0.140 |
Why?
|
Sclerosis | 1 | 2016 | 213 | 0.140 |
Why?
|
Physical Examination | 1 | 2022 | 1237 | 0.140 |
Why?
|
Statistics, Nonparametric | 5 | 2013 | 2887 | 0.140 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 4 | 2014 | 1107 | 0.140 |
Why?
|
Salivary Proteins and Peptides | 1 | 2016 | 53 | 0.130 |
Why?
|
Nasal Mucosa | 1 | 2018 | 373 | 0.130 |
Why?
|
Exploratory Behavior | 3 | 2016 | 270 | 0.130 |
Why?
|
Smoking Cessation | 1 | 2008 | 2071 | 0.130 |
Why?
|
Glutamic Acid | 2 | 2012 | 1169 | 0.130 |
Why?
|
Lidocaine | 2 | 2016 | 544 | 0.130 |
Why?
|
Software | 1 | 2010 | 4441 | 0.130 |
Why?
|
Acupuncture Analgesia | 1 | 2015 | 62 | 0.130 |
Why?
|
Electrodiagnosis | 1 | 2016 | 151 | 0.130 |
Why?
|
Injections, Spinal | 1 | 2016 | 303 | 0.130 |
Why?
|
Video Recording | 2 | 2019 | 949 | 0.130 |
Why?
|
Respiratory Insufficiency | 1 | 2004 | 1199 | 0.130 |
Why?
|
Erythema | 1 | 2016 | 257 | 0.130 |
Why?
|
Hydrocortisone | 2 | 2014 | 1826 | 0.130 |
Why?
|
Personality Inventory | 2 | 2008 | 1030 | 0.130 |
Why?
|
Analgesics, Opioid | 2 | 2021 | 3677 | 0.130 |
Why?
|
Paraplegia | 1 | 2015 | 169 | 0.130 |
Why?
|
Hot Flashes | 1 | 2017 | 316 | 0.130 |
Why?
|
Morbidity | 1 | 2020 | 1768 | 0.130 |
Why?
|
Schizophrenia | 5 | 2014 | 6882 | 0.120 |
Why?
|
Ethics Committees, Research | 1 | 2016 | 194 | 0.120 |
Why?
|
Sciatic Nerve | 4 | 2020 | 607 | 0.120 |
Why?
|
Periodicals as Topic | 2 | 2019 | 1431 | 0.120 |
Why?
|
Nursing Process | 1 | 2014 | 16 | 0.120 |
Why?
|
Dyspnea | 1 | 2022 | 1303 | 0.120 |
Why?
|
HTLV-I Infections | 1 | 2014 | 101 | 0.120 |
Why?
|
Radionuclide Imaging | 2 | 2010 | 2031 | 0.120 |
Why?
|
Clinical Protocols | 4 | 2017 | 1461 | 0.120 |
Why?
|
Amphetamine-Related Disorders | 1 | 2014 | 67 | 0.120 |
Why?
|
Cell Survival | 2 | 2023 | 5882 | 0.120 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2016 | 504 | 0.120 |
Why?
|
Remission Induction | 2 | 2010 | 2385 | 0.120 |
Why?
|
Dry Eye Syndromes | 1 | 2018 | 386 | 0.120 |
Why?
|
Thinking | 1 | 2016 | 318 | 0.120 |
Why?
|
Amputation Stumps | 1 | 2013 | 39 | 0.120 |
Why?
|
Schizophrenia, Catatonic | 1 | 2013 | 7 | 0.120 |
Why?
|
Regression Analysis | 2 | 2016 | 6459 | 0.110 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2017 | 300 | 0.110 |
Why?
|
Temporomandibular Joint Dysfunction Syndrome | 1 | 2012 | 23 | 0.110 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2012 | 4266 | 0.110 |
Why?
|
Consensus | 1 | 2022 | 2960 | 0.110 |
Why?
|
Cytokines | 3 | 2018 | 7323 | 0.110 |
Why?
|
Personal Satisfaction | 1 | 2017 | 643 | 0.110 |
Why?
|
Risk Factors | 9 | 2022 | 72296 | 0.110 |
Why?
|
Action Potentials | 1 | 2020 | 1806 | 0.110 |
Why?
|
Hallucinations | 2 | 2013 | 360 | 0.110 |
Why?
|
Cognitive Reserve | 1 | 2013 | 76 | 0.110 |
Why?
|
Demography | 3 | 2022 | 1655 | 0.110 |
Why?
|
Consciousness | 1 | 2018 | 572 | 0.110 |
Why?
|
Neurosecretory Systems | 1 | 2014 | 231 | 0.110 |
Why?
|
Vitiligo | 1 | 2013 | 89 | 0.110 |
Why?
|
Serotonin | 2 | 2014 | 1017 | 0.110 |
Why?
|
Injury Severity Score | 1 | 2015 | 1014 | 0.110 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2021 | 1534 | 0.100 |
Why?
|
Morale | 1 | 2011 | 12 | 0.100 |
Why?
|
Gait Disorders, Neurologic | 1 | 2014 | 231 | 0.100 |
Why?
|
Headache Disorders | 1 | 2014 | 130 | 0.100 |
Why?
|
Psychometrics | 2 | 2012 | 3003 | 0.100 |
Why?
|
Interpersonal Relations | 2 | 2011 | 1425 | 0.100 |
Why?
|
Cerebrovascular Circulation | 3 | 2014 | 2732 | 0.100 |
Why?
|
Task Performance and Analysis | 2 | 2017 | 780 | 0.100 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 501 | 0.100 |
Why?
|
Anesthetics, Local | 2 | 2016 | 985 | 0.100 |
Why?
|
Leukoaraiosis | 1 | 2012 | 120 | 0.100 |
Why?
|
Interleukin-1beta | 4 | 2020 | 972 | 0.100 |
Why?
|
Neostriatum | 1 | 2012 | 250 | 0.100 |
Why?
|
Thyroid Hormones | 1 | 2014 | 390 | 0.100 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2013 | 322 | 0.100 |
Why?
|
Electrodes, Implanted | 3 | 2014 | 824 | 0.100 |
Why?
|
Afferent Pathways | 1 | 2012 | 302 | 0.100 |
Why?
|
Stents | 1 | 2003 | 3282 | 0.100 |
Why?
|
Cerebral Hemorrhage | 1 | 2022 | 2647 | 0.100 |
Why?
|
Employment | 1 | 2017 | 1132 | 0.100 |
Why?
|
Feedback, Sensory | 1 | 2011 | 55 | 0.100 |
Why?
|
Tenodesis | 1 | 2011 | 49 | 0.100 |
Why?
|
Efferent Pathways | 1 | 2011 | 167 | 0.100 |
Why?
|
Interleukin-6 | 2 | 2023 | 3203 | 0.090 |
Why?
|
Vestibular Function Tests | 1 | 2011 | 127 | 0.090 |
Why?
|
Pain, Referred | 1 | 2010 | 5 | 0.090 |
Why?
|
Inflammation | 4 | 2023 | 10637 | 0.090 |
Why?
|
User-Computer Interface | 2 | 2017 | 1431 | 0.090 |
Why?
|
Neglected Diseases | 1 | 2011 | 64 | 0.090 |
Why?
|
Headache | 3 | 2023 | 1226 | 0.090 |
Why?
|
Friends | 1 | 2011 | 154 | 0.090 |
Why?
|
Empathy | 1 | 2015 | 474 | 0.090 |
Why?
|
Musculoskeletal System | 1 | 2012 | 175 | 0.090 |
Why?
|
Drug Resistance | 2 | 2006 | 1608 | 0.090 |
Why?
|
Illusions | 1 | 2010 | 60 | 0.090 |
Why?
|
Reproducibility of Results | 6 | 2017 | 19905 | 0.090 |
Why?
|
Models, Statistical | 2 | 2017 | 5101 | 0.090 |
Why?
|
Energy Intake | 2 | 2016 | 2148 | 0.090 |
Why?
|
Lactation | 1 | 2012 | 412 | 0.090 |
Why?
|
Longitudinal Studies | 4 | 2019 | 13991 | 0.090 |
Why?
|
Sunburn | 1 | 2010 | 155 | 0.090 |
Why?
|
Mental Recall | 1 | 2016 | 1206 | 0.090 |
Why?
|
Suicide | 1 | 2020 | 1474 | 0.090 |
Why?
|
Europe | 1 | 2016 | 3338 | 0.090 |
Why?
|
Developing Countries | 1 | 2022 | 2815 | 0.090 |
Why?
|
Food | 1 | 2014 | 772 | 0.090 |
Why?
|
Femur | 2 | 2012 | 1297 | 0.090 |
Why?
|
Epidemiologic Research Design | 1 | 2013 | 367 | 0.080 |
Why?
|
Scalp | 1 | 2012 | 380 | 0.080 |
Why?
|
Risk | 3 | 2010 | 9688 | 0.080 |
Why?
|
Age Factors | 3 | 2017 | 18373 | 0.080 |
Why?
|
Space Perception | 1 | 2012 | 475 | 0.080 |
Why?
|
Mortality | 1 | 2020 | 2864 | 0.080 |
Why?
|
Online Systems | 1 | 2010 | 184 | 0.080 |
Why?
|
Brain Chemistry | 1 | 2012 | 982 | 0.080 |
Why?
|
Multimedia | 1 | 2009 | 77 | 0.080 |
Why?
|
False Negative Reactions | 1 | 2010 | 588 | 0.080 |
Why?
|
Pituitary-Adrenal System | 1 | 2012 | 553 | 0.080 |
Why?
|
Benzothiazoles | 1 | 2010 | 248 | 0.080 |
Why?
|
Down Syndrome | 1 | 2017 | 880 | 0.080 |
Why?
|
Perceptual Disorders | 1 | 2010 | 196 | 0.080 |
Why?
|
Cold Temperature | 1 | 2012 | 772 | 0.080 |
Why?
|
Preoperative Care | 1 | 2017 | 2251 | 0.080 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 4328 | 0.080 |
Why?
|
Postmenopause | 1 | 2017 | 2460 | 0.080 |
Why?
|
Synapses | 2 | 2016 | 1728 | 0.080 |
Why?
|
Alcohol Drinking | 1 | 2021 | 3966 | 0.080 |
Why?
|
Neurons | 3 | 2020 | 9340 | 0.080 |
Why?
|
Statistics as Topic | 3 | 2015 | 2373 | 0.080 |
Why?
|
Athletic Injuries | 3 | 2012 | 1154 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6539 | 0.080 |
Why?
|
Cohort Studies | 3 | 2023 | 40559 | 0.080 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2012 | 703 | 0.080 |
Why?
|
Risk Assessment | 4 | 2017 | 23336 | 0.080 |
Why?
|
Saliva | 1 | 2012 | 809 | 0.080 |
Why?
|
Visual Fields | 2 | 2012 | 1047 | 0.080 |
Why?
|
Periodicity | 2 | 2008 | 364 | 0.080 |
Why?
|
Iran | 1 | 2010 | 710 | 0.080 |
Why?
|
Child, Preschool | 6 | 2016 | 41005 | 0.080 |
Why?
|
Electrophysiology | 2 | 2008 | 1308 | 0.080 |
Why?
|
Health Status | 1 | 2021 | 4034 | 0.080 |
Why?
|
Angiography, Digital Subtraction | 2 | 2006 | 341 | 0.080 |
Why?
|
Anxiety Disorders | 2 | 2022 | 2690 | 0.080 |
Why?
|
Anesthesia Recovery Period | 1 | 2008 | 157 | 0.070 |
Why?
|
Data Interpretation, Statistical | 2 | 2008 | 2716 | 0.070 |
Why?
|
Databases, Factual | 2 | 2015 | 7730 | 0.070 |
Why?
|
Symbolism | 1 | 2007 | 34 | 0.070 |
Why?
|
Phosphenes | 1 | 2007 | 44 | 0.070 |
Why?
|
Dopamine Agonists | 1 | 2010 | 355 | 0.070 |
Why?
|
Bibliometrics | 1 | 2011 | 339 | 0.070 |
Why?
|
Biofeedback, Psychology | 1 | 2007 | 115 | 0.070 |
Why?
|
Postoperative Care | 1 | 2014 | 1487 | 0.070 |
Why?
|
Semantics | 2 | 2008 | 585 | 0.070 |
Why?
|
Education, Medical, Continuing | 1 | 2012 | 840 | 0.070 |
Why?
|
Psychotropic Drugs | 2 | 2009 | 894 | 0.070 |
Why?
|
Carotid Arteries | 1 | 2011 | 950 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2018 | 3084 | 0.070 |
Why?
|
Stereotaxic Techniques | 2 | 2008 | 536 | 0.070 |
Why?
|
Benzodiazepines | 1 | 2012 | 1101 | 0.070 |
Why?
|
Dopamine | 1 | 2014 | 1591 | 0.070 |
Why?
|
Limbic System | 1 | 2009 | 426 | 0.070 |
Why?
|
Acute Disease | 2 | 2014 | 7147 | 0.070 |
Why?
|
Endpoint Determination | 1 | 2009 | 601 | 0.070 |
Why?
|
Secondary Prevention | 1 | 2013 | 1530 | 0.070 |
Why?
|
Visceral Afferents | 1 | 2005 | 9 | 0.070 |
Why?
|
Aging | 3 | 2023 | 8664 | 0.070 |
Why?
|
Radiation | 1 | 2005 | 49 | 0.070 |
Why?
|
Arousal | 2 | 2015 | 1164 | 0.070 |
Why?
|
Perception | 1 | 2013 | 1198 | 0.070 |
Why?
|
Israel | 1 | 2008 | 796 | 0.070 |
Why?
|
Review Literature as Topic | 1 | 2008 | 336 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3020 | 0.070 |
Why?
|
International Cooperation | 2 | 2011 | 1420 | 0.070 |
Why?
|
Psychiatry | 2 | 2008 | 1695 | 0.070 |
Why?
|
Proteome | 1 | 2016 | 1798 | 0.070 |
Why?
|
Gastrointestinal Diseases | 1 | 2014 | 1170 | 0.070 |
Why?
|
Malnutrition | 1 | 2012 | 625 | 0.070 |
Why?
|
Acetylcholine | 1 | 2007 | 621 | 0.070 |
Why?
|
Drug Synergism | 1 | 2010 | 1794 | 0.070 |
Why?
|
Mathematics | 1 | 2007 | 728 | 0.070 |
Why?
|
Thoracic Vertebrae | 1 | 2010 | 608 | 0.070 |
Why?
|
Educational Status | 1 | 2013 | 2540 | 0.060 |
Why?
|
Brain Damage, Chronic | 1 | 2006 | 265 | 0.060 |
Why?
|
Nerve Growth Factors | 1 | 2008 | 574 | 0.060 |
Why?
|
Speech Acoustics | 1 | 2006 | 151 | 0.060 |
Why?
|
Adaptation, Physiological | 2 | 2012 | 1312 | 0.060 |
Why?
|
Potassium Chloride | 1 | 2005 | 237 | 0.060 |
Why?
|
Amitriptyline | 1 | 2005 | 110 | 0.060 |
Why?
|
Overweight | 1 | 2016 | 2371 | 0.060 |
Why?
|
Occupational Therapy | 1 | 2006 | 134 | 0.060 |
Why?
|
Dystonia | 1 | 2008 | 363 | 0.060 |
Why?
|
Life Change Events | 1 | 2009 | 938 | 0.060 |
Why?
|
Professional-Patient Relations | 1 | 2010 | 737 | 0.060 |
Why?
|
Arteries | 1 | 2009 | 1119 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2023 | 2307 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 2305 | 0.060 |
Why?
|
Suicidal Ideation | 1 | 2013 | 1246 | 0.060 |
Why?
|
Communicable Disease Control | 1 | 2011 | 856 | 0.060 |
Why?
|
Carotid Stenosis | 1 | 2011 | 854 | 0.060 |
Why?
|
Voice Quality | 1 | 2006 | 217 | 0.060 |
Why?
|
Cannabis | 1 | 2010 | 440 | 0.060 |
Why?
|
Weight-Bearing | 1 | 2006 | 515 | 0.060 |
Why?
|
Nutritional Status | 1 | 2012 | 1609 | 0.060 |
Why?
|
Mental Status Schedule | 1 | 2004 | 321 | 0.060 |
Why?
|
Neurofeedback | 2 | 2014 | 40 | 0.060 |
Why?
|
Dysarthria | 1 | 2003 | 57 | 0.060 |
Why?
|
Neural Conduction | 1 | 2005 | 440 | 0.060 |
Why?
|
Hypnosis | 2 | 2014 | 82 | 0.060 |
Why?
|
Chi-Square Distribution | 4 | 2013 | 3508 | 0.060 |
Why?
|
Skin | 2 | 2016 | 4372 | 0.060 |
Why?
|
Alexia, Pure | 1 | 2003 | 2 | 0.060 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2016 | 2104 | 0.060 |
Why?
|
Hemifacial Spasm | 1 | 2003 | 23 | 0.060 |
Why?
|
Games, Experimental | 2 | 2014 | 32 | 0.060 |
Why?
|
Association Learning | 1 | 2005 | 224 | 0.060 |
Why?
|
Patient Compliance | 1 | 2014 | 2684 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2009 | 1953 | 0.060 |
Why?
|
Accidental Falls | 1 | 2011 | 1062 | 0.050 |
Why?
|
Median Nerve | 1 | 2023 | 129 | 0.050 |
Why?
|
Treatment Failure | 1 | 2009 | 2618 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2016 | 77460 | 0.050 |
Why?
|
Linear Models | 4 | 2016 | 5953 | 0.050 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2005 | 434 | 0.050 |
Why?
|
Mental Processes | 1 | 2004 | 249 | 0.050 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2003 | 45 | 0.050 |
Why?
|
Educational Measurement | 1 | 2010 | 1210 | 0.050 |
Why?
|
Hospitalization | 1 | 2022 | 10259 | 0.050 |
Why?
|
Receptors, Opioid, mu | 1 | 2023 | 182 | 0.050 |
Why?
|
Nociceptors | 1 | 2006 | 432 | 0.050 |
Why?
|
Syndrome | 1 | 2009 | 3252 | 0.050 |
Why?
|
Osteoporosis | 1 | 2012 | 1579 | 0.050 |
Why?
|
Caribbean Region | 1 | 2023 | 194 | 0.050 |
Why?
|
Checklist | 1 | 2009 | 833 | 0.050 |
Why?
|
Logistic Models | 2 | 2008 | 13409 | 0.050 |
Why?
|
Informed Consent | 1 | 2009 | 995 | 0.050 |
Why?
|
Auditory Cortex | 1 | 2006 | 346 | 0.050 |
Why?
|
Visual Cortex | 1 | 2010 | 1149 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2013 | 2265 | 0.050 |
Why?
|
Incidence | 1 | 2020 | 20952 | 0.050 |
Why?
|
Acoustic Stimulation | 1 | 2006 | 1216 | 0.050 |
Why?
|
Synaptic Transmission | 1 | 2008 | 1178 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 2 | 2006 | 1443 | 0.050 |
Why?
|
Surgical Procedures, Operative | 1 | 2014 | 1877 | 0.050 |
Why?
|
Social Perception | 1 | 2005 | 425 | 0.050 |
Why?
|
Anaphylaxis | 1 | 2009 | 746 | 0.050 |
Why?
|
Radiometry | 1 | 2007 | 800 | 0.050 |
Why?
|
Deltaproteobacteria | 1 | 2021 | 8 | 0.050 |
Why?
|
Oscillometry | 1 | 2021 | 147 | 0.050 |
Why?
|
Cerebral Infarction | 1 | 2006 | 1011 | 0.050 |
Why?
|
Data Collection | 1 | 2011 | 3339 | 0.050 |
Why?
|
Schizophrenic Psychology | 1 | 2009 | 1678 | 0.050 |
Why?
|
Immunity | 1 | 2007 | 1014 | 0.050 |
Why?
|
Head | 1 | 2007 | 880 | 0.050 |
Why?
|
Biophysics | 2 | 2014 | 383 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2014 | 6234 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 12073 | 0.050 |
Why?
|
Meditation | 2 | 2014 | 242 | 0.050 |
Why?
|
Kindling, Neurologic | 1 | 2020 | 30 | 0.050 |
Why?
|
Pentylenetetrazole | 1 | 2020 | 69 | 0.050 |
Why?
|
Oxyhemoglobins | 1 | 2021 | 216 | 0.050 |
Why?
|
Convulsants | 1 | 2020 | 70 | 0.050 |
Why?
|
Ischemic Attack, Transient | 1 | 2006 | 935 | 0.050 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2003 | 475 | 0.050 |
Why?
|
Interleukin-1alpha | 1 | 2020 | 85 | 0.050 |
Why?
|
Fingers | 1 | 2023 | 513 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2012 | 2400 | 0.040 |
Why?
|
Students | 1 | 2010 | 1647 | 0.040 |
Why?
|
Rats, Long-Evans | 1 | 2020 | 387 | 0.040 |
Why?
|
Recurrence | 2 | 2009 | 8340 | 0.040 |
Why?
|
Body Temperature | 1 | 2023 | 777 | 0.040 |
Why?
|
Diazepam | 1 | 2020 | 205 | 0.040 |
Why?
|
Nerve Growth Factor | 1 | 2020 | 149 | 0.040 |
Why?
|
Receptor, trkB | 1 | 2020 | 125 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2013 | 10943 | 0.040 |
Why?
|
Vision Disorders | 1 | 2006 | 1058 | 0.040 |
Why?
|
Education, Medical | 1 | 2011 | 1722 | 0.040 |
Why?
|
History, 20th Century | 3 | 2013 | 2740 | 0.040 |
Why?
|
Obesity | 2 | 2018 | 12746 | 0.040 |
Why?
|
Noise | 1 | 2021 | 279 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2278 | 0.040 |
Why?
|
Blood Pressure | 1 | 2014 | 8551 | 0.040 |
Why?
|
Sesquiterpenes | 1 | 2019 | 177 | 0.040 |
Why?
|
Alkaloids | 1 | 2019 | 190 | 0.040 |
Why?
|
Neoplasms | 1 | 2007 | 21696 | 0.040 |
Why?
|
Anterior Cruciate Ligament | 2 | 2012 | 415 | 0.040 |
Why?
|
Rats, Inbred WKY | 1 | 2018 | 158 | 0.040 |
Why?
|
Rats, Inbred SHR | 1 | 2018 | 195 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15078 | 0.040 |
Why?
|
Sulfur Compounds | 1 | 2017 | 31 | 0.040 |
Why?
|
Cell Death | 1 | 2023 | 1707 | 0.040 |
Why?
|
Cervical Vertebrae | 1 | 2004 | 976 | 0.040 |
Why?
|
Dementia | 1 | 2011 | 2518 | 0.040 |
Why?
|
Burns, Electric | 1 | 2017 | 42 | 0.040 |
Why?
|
Sex Factors | 3 | 2020 | 10400 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14723 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2023 | 15520 | 0.040 |
Why?
|
History, 19th Century | 2 | 2010 | 720 | 0.040 |
Why?
|
Muscle Spasticity | 1 | 2017 | 154 | 0.040 |
Why?
|
Muscle Tonus | 1 | 2016 | 81 | 0.040 |
Why?
|
Administration, Oral | 1 | 2004 | 3914 | 0.040 |
Why?
|
Algorithms | 1 | 2017 | 13882 | 0.040 |
Why?
|
Breath Tests | 1 | 2017 | 280 | 0.030 |
Why?
|
Genotype | 2 | 2022 | 12952 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2008 | 3395 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2017 | 426 | 0.030 |
Why?
|
History, 21st Century | 2 | 2013 | 1534 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2008 | 3589 | 0.030 |
Why?
|
Survival Analysis | 1 | 2009 | 10252 | 0.030 |
Why?
|
Appetite Regulation | 1 | 2016 | 88 | 0.030 |
Why?
|
Prognosis | 3 | 2017 | 29060 | 0.030 |
Why?
|
Apoptosis | 2 | 2023 | 9724 | 0.030 |
Why?
|
Organ Specificity | 1 | 2020 | 2008 | 0.030 |
Why?
|
Autistic Disorder | 1 | 2005 | 1185 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2011 | 3444 | 0.030 |
Why?
|
Alleles | 2 | 2019 | 6933 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2023 | 16690 | 0.030 |
Why?
|
Homeostasis | 1 | 2006 | 3339 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2011 | 8949 | 0.030 |
Why?
|
Reward | 2 | 2014 | 940 | 0.030 |
Why?
|
Social Control, Informal | 1 | 2014 | 46 | 0.030 |
Why?
|
Gyrus Cinguli | 2 | 2014 | 1091 | 0.030 |
Why?
|
Pupil | 1 | 2015 | 149 | 0.030 |
Why?
|
Rhode Island | 1 | 2014 | 347 | 0.030 |
Why?
|
Administration, Sublingual | 1 | 2013 | 56 | 0.030 |
Why?
|
Reference Standards | 1 | 2017 | 1025 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2003 | 2288 | 0.030 |
Why?
|
Handwriting | 1 | 2012 | 28 | 0.030 |
Why?
|
Cerebellar Ataxia | 1 | 2014 | 145 | 0.030 |
Why?
|
Event-Related Potentials, P300 | 1 | 2014 | 150 | 0.030 |
Why?
|
Body Weight | 2 | 2015 | 4671 | 0.030 |
Why?
|
Ovariectomy | 1 | 2015 | 661 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 20824 | 0.030 |
Why?
|
Sleep Deprivation | 1 | 2019 | 832 | 0.030 |
Why?
|
Freund's Adjuvant | 1 | 2012 | 139 | 0.030 |
Why?
|
Appetite | 1 | 2014 | 243 | 0.030 |
Why?
|
Gene Frequency | 1 | 2019 | 3587 | 0.030 |
Why?
|
Rotation | 1 | 2014 | 523 | 0.030 |
Why?
|
Cell Cycle | 1 | 2020 | 2967 | 0.030 |
Why?
|
Cats | 1 | 2013 | 1000 | 0.030 |
Why?
|
Auditory Perceptual Disorders | 1 | 2011 | 36 | 0.030 |
Why?
|
Radiography | 1 | 2003 | 7023 | 0.030 |
Why?
|
Corticosterone | 1 | 2012 | 310 | 0.030 |
Why?
|
Central Nervous System Depressants | 1 | 2012 | 167 | 0.030 |
Why?
|
Eating | 1 | 2018 | 1536 | 0.030 |
Why?
|
Psychological Tests | 1 | 2014 | 651 | 0.020 |
Why?
|
Tunica Media | 1 | 2011 | 113 | 0.020 |
Why?
|
Oxygen | 3 | 2010 | 4189 | 0.020 |
Why?
|
Observer Variation | 1 | 2017 | 2593 | 0.020 |
Why?
|
Choline | 1 | 2012 | 493 | 0.020 |
Why?
|
Probability | 1 | 2016 | 2506 | 0.020 |
Why?
|
Needles | 1 | 2014 | 449 | 0.020 |
Why?
|
Carbon Monoxide | 1 | 2014 | 531 | 0.020 |
Why?
|
Epistasis, Genetic | 1 | 2013 | 365 | 0.020 |
Why?
|
Maze Learning | 1 | 2012 | 478 | 0.020 |
Why?
|
Brain Stem | 1 | 2015 | 846 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2013 | 629 | 0.020 |
Why?
|
Signal Detection, Psychological | 1 | 2010 | 85 | 0.020 |
Why?
|
Hypothalamus | 1 | 2016 | 1063 | 0.020 |
Why?
|
United States | 2 | 2015 | 69872 | 0.020 |
Why?
|
Bone Nails | 1 | 2011 | 219 | 0.020 |
Why?
|
Forearm | 1 | 2012 | 409 | 0.020 |
Why?
|
Wrist | 1 | 2011 | 224 | 0.020 |
Why?
|
Visual Field Tests | 1 | 2012 | 383 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3582 | 0.020 |
Why?
|
Acupuncture Therapy | 1 | 2014 | 464 | 0.020 |
Why?
|
Uncertainty | 1 | 2014 | 735 | 0.020 |
Why?
|
Bioethical Issues | 1 | 2010 | 124 | 0.020 |
Why?
|
Speech Production Measurement | 1 | 2009 | 99 | 0.020 |
Why?
|
Hypertension | 1 | 2009 | 8479 | 0.020 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2012 | 366 | 0.020 |
Why?
|
Exercise Movement Techniques | 1 | 2009 | 11 | 0.020 |
Why?
|
Self Disclosure | 1 | 2010 | 251 | 0.020 |
Why?
|
Electric Impedance | 1 | 2013 | 729 | 0.020 |
Why?
|
Tunica Intima | 1 | 2011 | 464 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2013 | 841 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2020 | 3771 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2014 | 719 | 0.020 |
Why?
|
Magnetoencephalography | 1 | 2012 | 624 | 0.020 |
Why?
|
Nontherapeutic Human Experimentation | 1 | 2008 | 24 | 0.020 |
Why?
|
Eye Movements | 1 | 2012 | 507 | 0.020 |
Why?
|
Phenylcarbamates | 1 | 2007 | 38 | 0.020 |
Why?
|
Coronary Disease | 1 | 2003 | 6077 | 0.020 |
Why?
|
Americas | 1 | 2008 | 111 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2008 | 25628 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3873 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2013 | 1364 | 0.020 |
Why?
|
Neurosurgery | 1 | 2014 | 643 | 0.020 |
Why?
|
Osteoarthritis | 1 | 2015 | 1036 | 0.020 |
Why?
|
ROC Curve | 1 | 2015 | 3528 | 0.020 |
Why?
|
Bone Screws | 1 | 2011 | 520 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2019 | 2624 | 0.020 |
Why?
|
Endometriosis | 1 | 2015 | 839 | 0.020 |
Why?
|
Health Surveys | 1 | 2017 | 4036 | 0.020 |
Why?
|
Protons | 1 | 2012 | 1127 | 0.020 |
Why?
|
Darkness | 1 | 2007 | 167 | 0.020 |
Why?
|
Tectum Mesencephali | 1 | 2006 | 20 | 0.020 |
Why?
|
Exercise Test | 1 | 2014 | 2073 | 0.020 |
Why?
|
Sensory Deprivation | 1 | 2007 | 109 | 0.020 |
Why?
|
Infant | 1 | 2008 | 35134 | 0.020 |
Why?
|
Temperament | 1 | 2008 | 283 | 0.020 |
Why?
|
Cholinesterase Inhibitors | 1 | 2007 | 238 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2014 | 1486 | 0.020 |
Why?
|
Expressed Emotion | 1 | 2006 | 92 | 0.020 |
Why?
|
Rheumatic Diseases | 1 | 2012 | 593 | 0.020 |
Why?
|
Visual Pathways | 1 | 2010 | 565 | 0.020 |
Why?
|
Italy | 1 | 2008 | 832 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15221 | 0.020 |
Why?
|
Ethics, Medical | 1 | 2010 | 792 | 0.020 |
Why?
|
Neuropsychology | 1 | 2006 | 110 | 0.020 |
Why?
|
Mice | 1 | 2012 | 81201 | 0.020 |
Why?
|
Scattering, Radiation | 1 | 2007 | 498 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2019 | 3265 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 2011 | 1578 | 0.020 |
Why?
|
Weight Loss | 1 | 2016 | 2625 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8432 | 0.020 |
Why?
|
Face | 1 | 2010 | 994 | 0.020 |
Why?
|
Sleep, REM | 1 | 2007 | 595 | 0.010 |
Why?
|
Drug Discovery | 1 | 2012 | 1058 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 2 | 2009 | 4042 | 0.010 |
Why?
|
Phonetics | 1 | 2005 | 206 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21748 | 0.010 |
Why?
|
Anomia | 1 | 2003 | 14 | 0.010 |
Why?
|
Atrophy | 1 | 2008 | 1584 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3553 | 0.010 |
Why?
|
Diagnostic Imaging | 2 | 2008 | 3508 | 0.010 |
Why?
|
Basal Ganglia | 1 | 2005 | 546 | 0.010 |
Why?
|
Mood Disorders | 1 | 2008 | 1106 | 0.010 |
Why?
|
Neuromuscular Agents | 1 | 2003 | 134 | 0.010 |
Why?
|
Botulinum Toxins | 1 | 2003 | 191 | 0.010 |
Why?
|
Blindness | 1 | 2005 | 615 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12356 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11366 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 5984 | 0.010 |
Why?
|
Anticoagulants | 1 | 2014 | 4600 | 0.010 |
Why?
|
Amygdala | 1 | 2006 | 1315 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2007 | 1928 | 0.010 |
Why?
|
Decompression, Surgical | 1 | 2003 | 594 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13693 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2006 | 2897 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15160 | 0.000 |
Why?
|